Cargando…
Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
AIMS: Heart failure with preserved ejection fraction (HFpEF) is common and its management remains difficult. B-type natriuretic peptide (BNP) levels are used to diagnose heart failure, and as an entry criterion for inclusion into trials. We investigated a population of HFpEF patients who had been ra...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796061/ https://www.ncbi.nlm.nih.gov/pubmed/26940695 http://dx.doi.org/10.1007/s12471-016-0816-8 |
_version_ | 1782421703022870528 |
---|---|
author | Meijers, W. C. Hoekstra, T. Jaarsma, T. van Veldhuisen, D. J. de Boer, R. A. |
author_facet | Meijers, W. C. Hoekstra, T. Jaarsma, T. van Veldhuisen, D. J. de Boer, R. A. |
author_sort | Meijers, W. C. |
collection | PubMed |
description | AIMS: Heart failure with preserved ejection fraction (HFpEF) is common and its management remains difficult. B-type natriuretic peptide (BNP) levels are used to diagnose heart failure, and as an entry criterion for inclusion into trials. We investigated a population of HFpEF patients who had been randomised into a study based on clinical parameters, and compared those with low BNP levels to those with elevated BNP levels. METHODS: We examined patients who had been enrolled in the Coordinating study evaluating Outcomes of Advising and Counselling in Heart Failure (COACH), with preserved left ventricular ejection fraction (LVEF ≥ 40 %), and compared those with low BNP (< 100 pg/ml; n = 30) to those with elevated BNP (≥ 100 pg/ml; n = 127). Baseline characteristics, comorbidities, biomarkers, quality of life, and outcome parameters (hospitalisations and death) were compared between the groups. To validate our findings, we repeated all analyses for NT-proBNP (< 300 pg/ml and ≥ 300 pg/ml). RESULTS: Patients were similar with regard to most clinical characteristics (including age, sex, and LVEF), biomarkers, and comorbidities. In contrast, patients with a low BNP had higher body mass index levels (31 kg/m(2) vs. 27 kg/m(2); p < 0.01) and lower cardiac troponin I (9 pg/ml vs. 15 pg/ml; p = 0.02). In addition, these patients were less frequently prescribed diuretics and beta-blockers. No differences in quality of life, heart failure related symptoms and the primary and secondary outcomes were observed between these groups. These observations were confirmed for NT-proBNP. CONCLUSION: Among the patients with clinically diagnosed HFpEF, those with low BNP are strikingly similar to those with elevated BNP levels, except for BMI, which was significantly higher in these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12471-016-0816-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4796061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Bohn Stafleu van Loghum |
record_format | MEDLINE/PubMed |
spelling | pubmed-47960612016-04-08 Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides Meijers, W. C. Hoekstra, T. Jaarsma, T. van Veldhuisen, D. J. de Boer, R. A. Neth Heart J Original Article AIMS: Heart failure with preserved ejection fraction (HFpEF) is common and its management remains difficult. B-type natriuretic peptide (BNP) levels are used to diagnose heart failure, and as an entry criterion for inclusion into trials. We investigated a population of HFpEF patients who had been randomised into a study based on clinical parameters, and compared those with low BNP levels to those with elevated BNP levels. METHODS: We examined patients who had been enrolled in the Coordinating study evaluating Outcomes of Advising and Counselling in Heart Failure (COACH), with preserved left ventricular ejection fraction (LVEF ≥ 40 %), and compared those with low BNP (< 100 pg/ml; n = 30) to those with elevated BNP (≥ 100 pg/ml; n = 127). Baseline characteristics, comorbidities, biomarkers, quality of life, and outcome parameters (hospitalisations and death) were compared between the groups. To validate our findings, we repeated all analyses for NT-proBNP (< 300 pg/ml and ≥ 300 pg/ml). RESULTS: Patients were similar with regard to most clinical characteristics (including age, sex, and LVEF), biomarkers, and comorbidities. In contrast, patients with a low BNP had higher body mass index levels (31 kg/m(2) vs. 27 kg/m(2); p < 0.01) and lower cardiac troponin I (9 pg/ml vs. 15 pg/ml; p = 0.02). In addition, these patients were less frequently prescribed diuretics and beta-blockers. No differences in quality of life, heart failure related symptoms and the primary and secondary outcomes were observed between these groups. These observations were confirmed for NT-proBNP. CONCLUSION: Among the patients with clinically diagnosed HFpEF, those with low BNP are strikingly similar to those with elevated BNP levels, except for BMI, which was significantly higher in these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12471-016-0816-8) contains supplementary material, which is available to authorized users. Bohn Stafleu van Loghum 2016-03-03 2016-04 /pmc/articles/PMC4796061/ /pubmed/26940695 http://dx.doi.org/10.1007/s12471-016-0816-8 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Meijers, W. C. Hoekstra, T. Jaarsma, T. van Veldhuisen, D. J. de Boer, R. A. Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides |
title | Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides |
title_full | Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides |
title_fullStr | Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides |
title_full_unstemmed | Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides |
title_short | Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides |
title_sort | patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796061/ https://www.ncbi.nlm.nih.gov/pubmed/26940695 http://dx.doi.org/10.1007/s12471-016-0816-8 |
work_keys_str_mv | AT meijerswc patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides AT hoekstrat patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides AT jaarsmat patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides AT vanveldhuisendj patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides AT deboerra patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides |